1-6 of 6
Jesper Zeuthen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma

Per Guldberg, Per thor Straten, Anette Birck, Vibeke Ahrenkiel, Alexei F. Kirkin, Jesper Zeuthen
Journal: Cancer Research
Cancer Res (1997) 57 (17): 3660–3663.
Published: 01 September 1997
View article titled, Disruption of the <em>MMAC1/PTEN</em> Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma
Open the PDF for Disruption of the <em>MMAC1/PTEN</em> Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma in another window
Journal Articles

Isolation of Novel HLA-DR Restricted Potential Tumor-associated Antigens from the Melanoma Cell Line FM3

Thomas Halder, Graham Pawelec, Alexei F. Kirkin, Jesper Zeuthen, Helmut E. Meyer, Li Kun, Hubert Kalbacher
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3238–3244.
Published: 01 August 1997
View article titled, Isolation of Novel HLA-DR Restricted Potential Tumor-associated Antigens from the Melanoma Cell Line FM3
Open the PDF for Isolation of Novel HLA-DR Restricted Potential Tumor-associated Antigens from the Melanoma Cell Line FM3 in another window
Journal Articles

The p16-cyclin D/Cdk4-pRb Pathway as a Functional Unit Frequently Altered in Melanoma Pathogenesis

Jirina Bartkova, Jiri Lukas, Per Guldberg, Jan Alsner, Alexei F. Kirkin, Jesper Zeuthen, Jiri Bartek
Journal: Cancer Research
Cancer Res (1996) 56 (23): 5475–5483.
Published: 01 December 1996
View article titled, The p16-cyclin D/Cdk4-pRb Pathway as a Functional Unit Frequently Altered in Melanoma Pathogenesis
Open the PDF for The p16-cyclin D/Cdk4-pRb Pathway as a Functional Unit Frequently Altered in Melanoma Pathogenesis in another window
Journal Articles

Blood Group ABO-related Glycosylation of Urothelial Cell Lines: Immunocytological, Enzymatic, and Genetic Characterization

Peter Meldgaard, Eric H. Holmes, Eric P. Bennett, Henrik Clausen, Jesper Zeuthen, Hans Wolf, Torben F. Ørntoft
Journal: Cancer Research
Cancer Res (1994) 54 (9): 2440–2447.
Published: 01 May 1994
View article titled, Blood Group ABO-related Glycosylation of Urothelial Cell Lines: Immunocytological, Enzymatic, and Genetic Characterization
Open the PDF for Blood Group ABO-related Glycosylation of Urothelial Cell Lines: Immunocytological, Enzymatic, and Genetic Characterization in another window
Journal Articles

Recombinant Interleukin-2 and Lymphokine-activated Killer Cell Treatment of Advanced Bladder Cancer: Clinical Results and Immunological Effects

Gregers Gautier Hermann, Poul Flemming Geertsen, Hans von der Maase, Kenneth Steven, Claus Andersen, Tage Hald, Jesper Zeuthen
Journal: Cancer Research
Cancer Res (1992) 52 (3): 726–733.
Published: 01 February 1992
View article titled, Recombinant Interleukin-2 and Lymphokine-activated Killer Cell Treatment of Advanced Bladder Cancer: Clinical Results and Immunological Effects
Open the PDF for Recombinant Interleukin-2 and Lymphokine-activated Killer Cell Treatment of Advanced Bladder Cancer: Clinical Results and Immunological Effects in another window
Journal Articles

Human-Human Hybridomas and Human Monoclonal Antibodies Obtained by Fusion of Lymph Node Lymphocytes from Breast Cancer Patients

Thomas B. Kjeldsen, Birgitte Bruun Rasmussen, Carsten Rose, Jesper Zeuthen
Journal: Cancer Research
Cancer Res (1988) 48 (11): 3208–3214.
Published: 01 June 1988
View article titled, Human-Human Hybridomas and Human Monoclonal Antibodies Obtained by Fusion of Lymph Node Lymphocytes from Breast Cancer Patients
Open the PDF for Human-Human Hybridomas and Human Monoclonal Antibodies Obtained by Fusion of Lymph Node Lymphocytes from Breast Cancer Patients in another window